Clinical Trials Browser

Phase NA × Lymphoma, Large B-Cell, Diffuse × Vincristine × Clear all

NCT05990985 2023-08-18

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

Phase NA Not yet recruiting

Lymphoma, Large B-Cell, Diffuse

NCT05777369 2023-03-21

R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma

Phase NA Unknown

Lymphoma, Large B-Cell, Diffuse

NCT00544219 2019-05-15

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Phase NA Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT03022123 2017-01-16

The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma

Phase NA Unknown

Lymphoma, Large B-Cell, Diffuse

NCT00110006 2010-06-11

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

Phase NA Withdrawn

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00689845 2009-07-08

Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma

Phase NA Unknown

Lymphoma, Lymphoma, Large B-Cell, Diffuse